检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张干[1] 苗青[1] 周媛[1] 孙静[1] 宫鑫[1]
机构地区:[1]蚌埠市神经病学防治研究所,蚌埠市第三人民医院神经内科,233000
出 处:《安徽医学》2009年第5期550-552,共3页Anhui Medical Journal
摘 要:目的观察依达拉奉对急性脑出血的临床疗效。方法将96例脑出血患者随机均分为治疗组和对照组,对照组48例采用常规治疗;治疗组48例在常规治疗的基础上给予依达拉奉应用共14天。两组均在治疗前及治疗后20天进行神经功能缺损评分、疗效评定及血清C-反应蛋白(CRP)含量测定。结果治疗组在20天后神经功能缺损评分改善明显优于对照组;疗效(有效率89%)优于对照组(有效率78%);治疗组CRP异常率(41.38%)显著低于对照组(54.35%)。结论依达拉奉可以减轻急性脑出血的炎症反应,降低神经功能缺损程度。Objective To observe the effect of edaravoneon on the treatment of acute cerebral hemorrhage. Methods 96 cases were divided into treatment group and control group randomly, 48 cases of control group were given treatment , and 48 cases of treatment group were given edaravone and conventional treatment for 14 days. Before and after 20 days, patoents in 2 groups were recorded on neurological function feficit scores, efficacy assessment and plasma level of C - reactive protein (CRP). Results After 20 days, the improvement of neurological function deficit scores of treatment group was superior to control group. And the efficacy of treatment group( efficiency: 89% ) was higher than control group( efficiency: 78% ). The CRP abnormal rate of treatment group (41.38%) were significantly lower than control group (54.35 % ) obviously. Conclusion Edaravone can reduce the inflammatory reaction and decrease the degree of neural function damage on acute cerebral hemorrhage.
分 类 号:R743.3[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249